Latest filing published 12 Aug 2026 for Hepion Pharmaceuticals, Inc., €87k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +12.9%Entry US$0.07 · Close at T+30 US$0.08
- -7.1%Entry US$0.07 · Close at T+90 US$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Vincent S. LoPriore: trading record in brief
Vincent S. LoPriore appears in our data through filings on Hepion Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 21 April 2026 and the latest from 3 August 2026.
Purchases make up the whole of the open-market record (4 purchases, €646k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
A typical purchase (the median) is worth €128k. Measured against the company's value, the median purchase equals 2.3% of market capitalisation, across 4 purchases where it is known. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 12 August 2026: an open-market purchase of €87k, in Hepion Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Vincent S. LoPriore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$0.051.74% mcap13.4% of flowCommon StockSEC:0001493152-26-037489:1Canonical exit: 1 Nov 2026 (T+90)
- 8,000,000 shares@ US$0.056.94% mcap67.1% of flowCommon StockSEC:0001493152-26-037489:0Canonical exit: 1 Nov 2026 (T+90)
- 5,000,000 shares@ US$0.042.94% mcap26.3% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-26-019029:0Canonical exit: 20 Jul 2026 (T+90)
- 1,250,000 shares@ US$0.040.74% mcap6.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-26-019029:1Canonical exit: 20 Jul 2026 (T+90)
4 of 2 declarations